Board Recertification Intensive Studies: Chronic Obstructive Pulmonary Disease: New Approaches to an Old Problem


New treatments for chronic obstructive pulmonary disease (COPD)—including monotherapy and combination agents approved by the U.S. Food and Drug Administration—raise questions for pharmacists about when and where to put these therapies to most effective use. In this interactive session, experts will use real-world cases to share practical approaches on how to assess patients with COPD. With a comparison of old versus new therapies, you will leave with the practical skills needed to manage patients in both inpatient and outpatient settings.

Select Intensive Studies for Recertification 2018 when you register for APhA2018  to purchase the intensive studies exam for BPS recertification credit. Cost: $50.00

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to: 

  1. Interpret data from clinical trials of newly approved therapeutic approaches for chronic obstructive pulmonary disease (COPD).
  2. Describe recommendations in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of COPD.
  3. Discuss the pros and cons of new and old approaches to managing COPD.
  4. Recommend appropriate therapy for COPD in patients across inpatient and outpatient settings.

Joint Providership

This activity is approved for board-certified ambulatory care pharmacist (BCACP) recertification credit.

Dennis Williams, PHARMD, FAPHA
University of North Carolina At Chapel Hill Eshelman School of Pharmacy
Lori Wilken, Pharm.D., BCACP
Clinical Pharmacist, Clinical Assistant Professor
University of Illinois at Chicago College of Pharmacy
Learning Level: Level 2
Track: Clinical Patient Care and Services, Board Recertification
Session Time Slot(s): 
Sunday, March 18
3:30 PM - 5:30 PM
Music City Center - Room 103C
ACPE Pharmacist: 0202-0000-18-011-L01-P
CEUs Pharmacist: 0.2
Activity Type: